Risk of severe immune-related adverse events in cancer patients with pre-existing autoimmunity receiving immune checkpoint inhibitor therapy
Related Posts
Jung W, Abushukair H, Patil NY, Ampadu F, Firouzi M, Rus I, Choi J, Muthukrishnan SD, Shukla S, Tarantini S, Csiszar A, Mehla K, Kim[...]
Sheshadri P, Costa-Besada MA, Fisher A, Kiraly S, Singh K, Kourouzidou I, Blacker TS, Zeng J, Shirihai OS, Grinstaff MW, Duchen MR. Targeting lysosomal pH[...]
Mulroy M, Primbas A, Salusky IB, Weinreb J, Shieh A. Management of Osteoporosis and Low Bone Mass in Kidney Disease. Clin J Am Soc Nephrol.[...]